Erlotinib in the treatment of advanced pancreatic cancer
Robin K Kelley, Andrew H KoUniversity of California, San Francisco, Comprehensive Cancer CenterAbstract: Single agent gemcitabine has been the mainstay of therapy for advanced pancreatic cancer over the past decade. Multiple trials of newer chemotherapeutic agents both alone and in combination have...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-03-01
|
| Series: | Biologics: Targets & Therapy |
| Online Access: | http://www.dovepress.com/erlotinib-in-the-treatment-of-advanced-pancreatic-cancer-a57 |